MedPath

A phase II trial of postoperative adjuvant chemotherapy with carboplatin/ docetaxel for the patients completely resected Non Small Cell Lung Cancer

Phase 2
Conditions
non-small cell lung cancer
Registration Number
JPRN-UMIN000002425
Lead Sponsor
niversity of Occupational and Environmental Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
65
Inclusion Criteria

Not provided

Exclusion Criteria

1)active infection 2)fever 3)severe complication 4)concomittant malignant cancer 5) Uncontroled pleural effusion or ascitis 6)Pericardial effusion 7)Neuropathy 8)past history of severe allergic reaction 9) Pregnant or expecting woman 10) other conditions not suitable for this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
feasibility
Secondary Outcome Measures
NameTimeMethod
safety, progression-free survival
© Copyright 2025. All Rights Reserved by MedPath